Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06354387
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-03-18
Brief Title:
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
Sponsor:
China Medical University Hospital
Organization:
China Medical University Hospital
Organization Data
Organization:
China Medical University Hospital
Class:
OTHER
Study ID:
CMUH110-REC3-246
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
China Medical University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Chang-Fang Chiu
Responsible Party Title:
superintendent
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
China Medical University Hospital
Old Name:
None
Old Organization:
None